Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 Return on Equity

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's return on equity stands at -9.2%. That is below the sector sector average of -5.68%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 sits lower the its sector benchmark (-5.68%) with a ROE of -9.2%. That is roughly 61.8% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of -9.2% for Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028 means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Aimei Health Technology Co Ltd - Tradeable Rights - Nov 2028's ROE evolved across reporting periods, while the comparison chart places AFJKR next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.